Aleksandar Savić
Full Professor
Clinical Center of Vojvodina, Clinic of Hematology
aleksandar.savic@mf.uns.ac.rs
Phone: 0214843963
ORCID ID : 0000-0002-5619-3724
Clinical Center of Vojvodina, Clinic of Hematology
aleksandar.savic@mf.uns.ac.rs
Phone: 0214843963
ORCID ID : 0000-0002-5619-3724
| Academic career | Year | Institution | Field |
|---|---|---|---|
Status Acquired |
2015 |
Faculty of Medicine Novi Sad |
Internal Medicine, Hematology | PhD |
2003 |
Faculty of Medicine Novi Sad |
Internal Medicine, Hematology |
Subspecialization |
1997 |
Faculty of Medicine Novi Sad |
Hematology |
Specialization |
1994 |
Faculty of Medicine Novi Sad |
Internal Medicine |
MSc |
1992 |
Faculty of Medicine Novi Sad |
Internal Medicine, Hematology |
Graduated |
1987 |
Faculty of Medicine Novi Sad |
General Medicine |
| M | Description |
|---|---|
22 | Savic A, Kvrgic V, Rajic N, Urosevic I, Kovacevic D, Percic I, Popovic S. The hematopoietic cell transplantation comorbidity index is a predictor of early death and survival in adult acute myeloid leukemia patients. Leuk Res 2012;36(4):479-82. |
23 | Savic A, Marisavljevic D, Kvrgic V, Stanisavljevic N. Validation of the Revised International Prognostic Scoring System for Patients with Myelodysplastic Syndromes. Acta Haematol 2013;131(4):231-238. |
23 | Savic A, Cemerikic-Martinovic V, Dovat S, Rajic N, Urosevic I, Sekulic B, Kvrgic V, Popovic S. Angiogenesis and survival in patients with myelodysplastic syndrome. Pathol Oncol Res 2012;18(3):681-90. |
21a | Tawana K, Wang J, Renneville A, Bödör C, Hills R, Loveday C , Savic A, et al. Disease evolution and outcomes in familial AML with germline CEBPA mutations. Blood 2015;126(10): 1214-23 |
21a | Stauder R, Yu G, Koinig KA, Bagguley М, Fenaux P, Symeonidis A, Sanz G, Cermak J, Mittelman M, Hellström-Lindberg E, Langemeijer S, Skov Holm M, Mądry K, Malcovati L, Tatic A, Germing U, Savic A, et al. Healthrelated quality of life in lower-risk MDS patients compared with age- and sexmatched reference populations: a European LeukemiaNet study. Leukemia. 2018;32(6):1380-1392. |
22 | Santagostino E, Lentz SR, Misgav M, Brand B, Chowdary P, Savic A, et al. Safety and efficacy of turoctocog alfa (NovoEight®) during surgery in patients with haemophilia A: results from the multinational guardian™ clinical trials. Haemophilia 2015 Jan;21(1):34-40. |
21a | Hoeks M, Yu G, Langemeijer S, Crouch S, de Swart L, Fenaux P, Symeonidis A, Cermák J, Hellström-Lindberg E, Sanz G, Stauder R, Skov Holm M, Mittelman M, Madry K, Malcovati L, Tatic A, Medina Almeida A, Germing U, Savic A, et al. Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry. Haematologica. 2019; 104:xxx doi:10.3324/haematol.2018.212332 |
21a | de Swart L, Crouch S, Hoeks M, Smith A, Langemeijer S, Fenaux P, Symeonidis A, Cermák J, Hellström-Lindberg E, Stauder R, Sanz G, Mittelman M, Skov Holm M, Malcovati L, Madry K, Germing U, Tatic A, Savic A, et al. Collaborative Groups: EUMDS Registry Participants). Impact of red blood cell transfusion dose density on progression-free survival in lower-risk myelodysplastic syndromes patients Haematologica. 2019; 104:xxx doi:10.3324/haematol.2018.212217 |
| Course | Studies |
|---|---|
Internal Medicine (Hematology); Clinical Propedeutics | Integrated academic studies in medicine |
Internal Medicine (Hematology) | Integrated academic studies in dentistry |
Internal Medicine (Hematology) | Doctoral academic studies - Clinical research |
Internal Medicine (Hematology); Clinical Propedeutics | Undergraduate applied studies in nursing |
Internal Medicine (Hematology); Clinical Propedeutics | Undergraduate academic studies in nursing |